A former pharmacy owner was sentenced to four years in prison Sept. 27 for fraudulently filling and dispensing thousands of prescription medications, including opioids, without a pharmacist license, according to a U.S. Justice Department news release.
Pharmacy
Rite Aid plans to focus on its relationship with health insurance plans to help its financial turnaround, rather than attempt another merger, according to Forbes.
CVS Pharmacy has suspended the sale of Zantac and other ranitidine products at its drugstores after the FDA flagged a possible human carcinogen in the popular heartburn drugs.
A 60-word provision in House Speaker Nancy Pelosi's drug-pricing plan could make it impossible for hospitals to get a 340B discount for any drug that Medicare negotiates for, according to STAT.
Pfizer's executive chairman Ian Read will retire at the end of the year, according to The Wall Street Journal.
Advertisement
Avanir Pharmaceuticals agreed to pay $116 million to settle a lawsuit alleging it illegally marketed its drug Nuedexta, according to STAT.
CMS plans to collect pricing and payment information from hospitals participating in the 340B drug discount program, according to a notice issued Sept. 26.
Mylan agreed to pay $30 million to settle a lawsuit claiming it failed to disclose to investors a 2017 U.S. Justice Department probe into whether it overcharged Medicaid for its EpiPen allergy treatment.
Seven drugs approved by the FDA since Aug. 19:
The FDA approved the first treatment for children with rare vasculitis diseases that cause inflammation of blood vessels and reduce blood flow to organs.